170355-38-1Relevant academic research and scientific papers
A Stable Blue Photosensitizer for Color Palette of Dye-Sensitized Solar Cells Reaching 12.6% Efficiency
Ren, Yameng,Sun, Danyang,Cao, Yiming,Tsao, Hoi Nok,Yuan, Yi,Zakeeruddin, Shaik M.,Wang, Peng,Gr?tzel, Michael
supporting information, p. 2405 - 2408 (2018/02/28)
We report a blue dye, coded as R6, which features a polycyclic aromatic hydrocarbon, 9,19-dihydrobenzo[1′,10′]phenanthro[3′,4′:4,5]thieno[3,2-b]benzo[1,10]phenanthro[3,4-d]thiophene, coupled with a diarylamine electron donor and 4-(7-ethynylbenzo[c][1,2,5]thiadiazol-4-yl)benzoic acid acceptor. Dye R6 displays a brilliant sapphire color in a sensitized TiO2 mesoporous film with a Co(II/III) tris(bipyridyl)-based redox electrolyte. The R6 based dye-sensitized solar cell achieves an impressive power conversion efficiency of 12.6% under standard air mass 1.5 global, 100 mW cm-2, and shows a remarkable photostability.
Anthracene-based fused ring aromatic hydrocarbon organic dye and preparation method thereof
-
Paragraph 0121; 0122, (2018/04/01)
The invention relates to the field of dye-sensitized solar cells, and aims to provide an anthracene-based fused ring aromatic hydrocarbon organic dye and a preparation method thereof. The molecular structural formula of the organic dye is as shown in the formula (I). The anthracene-based fused ring aromatic hydrocarbon organic dye is used for modifying an auxiliary electron donor D and an electronacceptor A on constructed anthracene-based fused ring aromatic hydrocarbon, so that when the organic dye prepared through the preparation method is applied to the dye-sensitized solar cells, the photoelectric conversion efficiency is high; the raw materials of the organic dye are wide in source, the cost is low, the preparation method is simple, and industrial production can be achieved. The molecular structural formula (I) is shown in the description.
THIENOPYRIDAZINE COMPOUNDS, THEIR PREPARATIONS, PHARMACEUTICAL COMPOSITIONS AND USES
-
Page/Page column 26, (2010/11/03)
The present invention relates to thienopyridazine compounds of formula (I), their pharmaceutically acceptable salts or hydrates, wherein R1 and R2 are independently H or C1-4 alkyl, R3 is a saturated or unsaturated 5- or 6- membered ring containing N, S or O, or its optical isomers, R4 is a halophenyl monosubstituted or disubstituted at any position. The present invention provides the preparation methods of these compounds, pharmaceutical compositions containing these compounds and the uses of these compounds, particularly in treating cancer.
Novel Compounds and Therapeutic Use Thereof for Protein Kinase Inhibition
-
Page/Page column 12; 16, (2009/12/02)
Novel compound having the following formula: Also disclosed are a pharmaceutical compositions comprising the same, methods for treating cancer using the same, and methods for the synthesis of the same. The novel compounds of the present invention are found to inhibit protein kinases, especially Checkpoint kinase Chk1/Chk2.
